Drug intelligence / Profile preview

Sinol-D

Development stage
Unknown
Lead developer
Sinol
Modality
Small Molecules
Administration
Intranasal
01

Overview

Sinol-D is an over-the-counter (OTC) homeopathic nasal spray developed by Sinol USA for the temporary relief of nasal congestion, sinus pressure, and headaches associated with allergies, sinusitis, and the common cold. The primary active ingredient in Sinol-D is Capsicum annuum (capsicum), which contains capsaicin, a potent agonist of the transient receptor potential vanilloid 1 (TRPV1) channel. Upon intranasal administration, capsaicin binds to TRPV1 receptors on sensory nerve fibers in the nasal mucosa, initially stimulating them and subsequently inducing a prolonged refractory period of desensitization. This desensitization reduces nasal hyperreactivity, alleviates mucosal inflammation, and decreases the release of neuropeptides like substance P, thereby relieving congestion and sinus pain without causing rebound congestion or habit-forming side effects.

Brand names
Sinol-D
Other names
Sinol-D All Natural DecongestantSinol-D All-Natural Nasal Spray Decongestant
02

Targets

TRPM8 (Transient receptor potential cation channel subfamily M member 8)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on Sinol-D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sinol-D.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call